home / stock / acad / acad news


ACAD News and Press, ACADIA Pharmaceuticals Inc. From 05/29/24

Stock Information

Company Name: ACADIA Pharmaceuticals Inc.
Stock Symbol: ACAD
Market: NASDAQ
Website: acadia-pharm.com

Menu

ACAD ACAD Quote ACAD Short ACAD News ACAD Articles ACAD Message Board
Get ACAD Alerts

News, Short Squeeze, Breakout and More Instantly...

ACAD - 3 Sorry Pharma Stocks to Sell in May While You Still Can

2024-05-29 10:01:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are some pharma stocks to sell in May this year. These companies have been grappling with various issues. These include pipeline setbacks, increasing competition, and regulatory hurdles. ...

ACAD - Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome

— Video series created by Rett caregiver and award-winning TV producer, AJ Tesler, and family, showcases the adapted adventures of families living with Rett syndrome — Documentary series to be showcased on Rett Revealed, a website designed to explain and highlight life with ...

ACAD - Cantor picks 14 undervalued biotech stocks worth a second look

2024-05-12 11:00:00 ET More on Acadia Pharma, BridgeBio Pharma, etc. ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript ACADIA Pharmaceuticals Inc. 2024 Q1 - Results - Earnings Call Presentation Rocket Pharmaceuticals: Cautiously Optimistic (Rating U...

ACAD - Trading (ACAD) With Integrated Risk Controls

2024-05-08 22:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

ACAD - ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Call Transcript

2024-05-08 21:00:09 ET ACADIA Pharmaceuticals Inc. (ACAD) Q1 2024 Earnings Conference Call May 8, 2024 16:30 ET Corporate Participants Al Kildani - Senior Vice President, Investor Relations and Corporate Communications Steve Davis - President and Chief Executive Offi...

ACAD - Acadia Pharma GAAP EPS of $0.10 beats by $0.05, revenue of $205.83M misses by $2.75M

2024-05-08 16:10:35 ET More on Acadia Pharma Evaluating Acadia's Market Position Following Pimavanserin's Clinical Setback Acadia Pharmaceuticals: Post Pimavanserin Study Setback Selloff May Continue Acadia Pharmaceuticals: New Daybue Drug Already Showing Signs Of Sl...

ACAD - Acadia Pharmaceuticals Reports First Quarter 2024 Financial Results and Operating Overview

- First quarter NUPLAZID ® (pimavanserin) net product sales of $129.9 million - First quarter DAYBUE ™ (trofinetide) net product sales of $75.9 million Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the first quarter ende...

ACAD - Expected US Company Earnings on Wednesday, May 8th, 2024

Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...

ACAD - Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more

2024-05-05 08:00:00 ET As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company ( NYSE: DIS ), Palantir Technologies ( NYSE: PLTR ), Realty Income ( NYSE: ...

ACAD - Buy Recommendation Issued On ACAD By UBS

2024-04-30 08:30:07 ET UBS analyst issues BUY recommendation for ACAD on April 30, 2024 06:00AM ET. The previous analyst recommendation was Buy. ACAD was trading at $17.1 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst rec...

Previous 10 Next 10